More News

• [Public Consultation] The 35 drug molecules or 72 formulations that were subjected under price review by a Joint Department of Health (DOH) and Department of Trade and Industry (DTI) Technical Working Group (TWG)
• [Public Consultation] Joint AO on the Constitution of the Price Negotiation Board and Implementing Guidelines on Price Negotiation for Innovative, Proprietary, Patented and Single-Sourced Health Commodities
• (Event) 11th Policy Dialogue on Unviersal Healthcare and Access to Medicines
• (HTA) Administrative Order 2020-0041 - The New Implementing Guidelines on Health Technology Assessment to Guide Funding Allocation and Coverage Decisions in support of Universal Health Care
• (HTA) Philippine Process Guide for Health Technology Assessment
• (HTA) Philippine Methods Guide for Health Technology Assessment
• (NEWS) Compliance to Executive Order No. 104, "Improving Access to Healthcare through the Regulations of Prices in the Retail of Drugs and Medicines"
• (NEWS) Maximum Retail Price IEC Poster Template, Now Available!!
• (PNF) Inclusion of 10- and 13-valent Pneumococcal Conjugate Vaccines (PCV) multidose preparation in the Philippine National Formulary
• Guidelines in the Implementation of Maximum Retail Price (MRP) on Drugs and Medicines
• (Announcement) Review of the Remaining Medicines for Maximum Retail Price
• (News)Evidence Summary on the Reassessment of 10- versus 13-valent Pneumococcal Conjugate Vaccines (PCV) in the Philippines
• Philippine National Formulary 8th Edition - Essential Medicines List 2019 (Updated as of July 23, 2020)
• (DM)List of 2019 PNF applications classified as Priority for evaluation and evidence review
• (DO)Guidelines on Ensuring the Affordability of Essential Medicines in DOH Facilities Through the Regulation of Price Mark-ups